BetterLife Pharma Announces Rescheduling and Reclassification of Annual General Meeting to Annual General and Special Meeting

$BETRPress releaseSep 29, 2026, 5:59 PM ETRead the release

BetterLife Pharma rescheduled its annual general meeting from October 14, 2026 to December 9, 2026, reclassifying it as an Annual General and Special Meeting. Shareholders will vote on standard annual matters plus special business items required to meet NASDAQ listing qualifications, with a record date of October 26, 2026.

Key figures

Record date: October 26, 2026
New meeting date: December 9, 2026
Original meeting date: October 14, 2026

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.